Back

SGLT2 inhibitors in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis

7 April 2022 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation Pharmacotherapy EAPC Premium Access ESC Preventive Cardiology 2022

About the speaker

Photo
Doctor Vasiliki Tsampasian

University of East Anglia, Norwich (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Ventricular-arterial coupling derived from proximal aortic stiffness: impact on aerobic capacity across the heart failure spectrum.
Doctor N. Pugliese (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort
Doctor P. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Insomnia was associated with increased risk of recurrent cardiovascular events in coronary heart disease patients
Mr L. Frojd (Drammen, NO)
Abstract Slides Video
Presentation thumbnail
Effects of once-weekly semaglutide on coronary outcomes in patients with type 2 diabetes mellitus with or at high risk for cardiovascular disease: insights from the SUSTAIN-6 trial
Doctor A. Kolkailah (Dallas, US)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation

The Event

Event poster

ESC Preventive Cardiology 2022

7 April - 9 April 2022
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources